Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 11, 2024 01:00 ET | Source: BioVersys

Bioversys Announces Strategic Investment From GIBF2 and Launch of BV100 Clinical Program in China

BASEL, Switzerland, Sept. 11, 2024 (GLOBE NEWSWIRE) -- GIBF2 to invest US$ 6m in BioVersys BV100 Phase 1 study in China expected to start in 1H 2025 in preparation for a global Phase 3...
June 04, 2024 01:00 ET | Source: BioVersys

BioVersys Awarded Non-Dilutive Funding From CF AMR Syndicate Collaborative Discovery Programme

BASEL, Switzerland, June 04, 2024 (GLOBE NEWSWIRE) -- CF AMR Syndicate awarded BioVersys up to £ 500,000 to support project addressing resistant non-tubercular mycobacteria (NTM) lung infections...
May 07, 2024 01:00 ET | Source: BioVersys

BioVersys Announces Expansion of Strategic Collaboration With GSK and Extension of Its Series C Round by CHF 12.3 Million

Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of tuberculosisGSK to participate in Series C Extension with equity investmentSeries C...